|
|
41
|
|
|
4181PB
|
|
|
SIMULECT 20MG INJ (NVS) BAILIXIMAB (C)
|
|
|
BASILIXIMAB
|
|
|
SIMULECT
|
|
|
20MG VIAL
|
|
|
C
|
|
|
4892.98
|
|
|
4892.9832
|
|
|
20MG
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|